Back to SYRE
PRICE T ROWE ASSOCIATES INC /MD/ → SYRE
PRICE T ROWE ASSOCIATES INC /MD/ SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
8
Latest value
$9.8M
Q3 2026
Peak value
$260.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $49.9M |
| Q4 2025 | $2.5M |
| Q1 2026 | $4.4M |
| Q1 2026 | $76.2M |
| Q2 2026 | $253.4M |
| Q2 2026 | $9.5M |
| Q3 2026 | $260.5M |
| Q3 2026 | $9.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $9.8M | 110.5K | — | — |
| Q3 2026 | $260.5M | 2.93M | — | — |
| Q2 2026 | $9.5M | 106.7K | — | — |
| Q2 2026 | $253.4M | 2.85M | — | — |
| Q1 2026 | $76.2M | 1.51M | — | — |
| Q1 2026 | $4.4M | 88.0K | — | — |
| Q4 2025 | $2.5M | 77.2K | — | — |
| Q4 2025 | $49.9M | 1.52M | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M
$336.7M